• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11C-胆碱 PET-CT 是否有助于前列腺癌定位的多参数 MRI?

Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?

机构信息

Department of Radiation Oncology, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium.

出版信息

Strahlenther Onkol. 2013 Sep;189(9):789-95. doi: 10.1007/s00066-013-0359-5.

DOI:10.1007/s00066-013-0359-5
PMID:23797481
Abstract

BACKGROUND AND PURPOSE

The aim of this work was to determine whether 11C-choline positron emission tomography (PET)-computed tomography (CT) makes a positive contribution to multiparametric magnetic resonance imaging (MRI) for localisation of intraprostatic tumour nodules.

PATIENTS AND METHODS

A total of 73 patients with biopsy-proven intermediate- and high-risk prostate cancer were enrolled in a prospective imaging study consisting of T2-weighted (T2w), dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MRI and 11C-choline PET-CT before radical prostatectomy. Cancerous regions were delineated on the whole-mount prostatectomy sections and on the different MRI modalities and analysed in 24 segments per patient (3 sections, 8 segments each). To analyse PET-CT images, standardized uptake values (SUV) were calculated per segment.

RESULTS

In total, 1,752 segments were analyzed of which 708 (40.4%) were found to be malignant. A high specificity (94.7, 93.6 and 92.2%) but relatively low sensitivity (31.2, 24.9 and 44.1%) for tumour localisation was obtained with T2w, DCE and DW MRI, respectively. Sensitivity values significantly increased when combining all MRI modalities (57.2%). For PET-CT, mean SUVmax of malignant octants was significantly higher than mean SUVmax of benign octants (3.68±1.30 vs. 3.12±1.02, p<0.0001). In terms of accuracy, the benefit of adding PET-CT to (multiparametric) MRI was less than 1%.

CONCLUSION

The additional value of 11C-choline PET-CT to MRI in localising intraprostatic tumour nodules is limited, especially when multiparametric MRI is used.

摘要

背景与目的

本研究旨在确定 11C-胆碱正电子发射断层扫描(PET)-计算机断层扫描(CT)是否能对前列腺内肿瘤结节的定位有积极贡献。

患者与方法

本前瞻性影像学研究共纳入 73 例经活检证实的中高危前列腺癌患者,他们在接受根治性前列腺切除术之前接受了 T2 加权(T2w)、动态对比增强(DCE)和弥散加权(DW)磁共振成像以及 11C-胆碱 PET-CT 检查。在整个前列腺切除标本上以及不同的 MRI 模式上描绘出癌灶,并对每位患者的 24 个节段(3 个切片,每个切片 8 个节段)进行分析。为了分析 PET-CT 图像,对每个节段计算标准化摄取值(SUV)。

结果

共分析了 1752 个节段,其中 708 个(40.4%)被发现为恶性。T2w、DCE 和 DW MRI 对肿瘤定位的特异性分别为 94.7%、93.6%和 92.2%,但敏感性相对较低(31.2%、24.9%和 44.1%)。当联合所有 MRI 模式时,敏感性值显著增加(57.2%)。对于 PET-CT,恶性节段的平均 SUVmax 明显高于良性节段(3.68±1.30 比 3.12±1.02,p<0.0001)。就准确性而言,将 PET-CT 添加到(多参数)MRI 中的获益小于 1%。

结论

11C-胆碱 PET-CT 对 MRI 定位前列腺内肿瘤结节的额外价值有限,特别是在使用多参数 MRI 时。

相似文献

1
Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?11C-胆碱 PET-CT 是否有助于前列腺癌定位的多参数 MRI?
Strahlenther Onkol. 2013 Sep;189(9):789-95. doi: 10.1007/s00066-013-0359-5.
2
Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?¹¹C-胆碱 PET-CT 对 T2 加权 MRI 图像在前列腺内肿瘤结节定位中的附加价值如何?
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1486-92. doi: 10.1016/j.ijrobp.2011.10.046. Epub 2012 Jan 26.
3
Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.PET/MRI融合成像在前列腺癌检测与定位中的诊断价值:多参数MRI与PET/CT的对比研究
J Magn Reson Imaging. 2017 Feb;45(2):597-609. doi: 10.1002/jmri.25384. Epub 2016 Sep 1.
4
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.[(11)C]胆碱正电子发射断层扫描与 T2 加权和弥散加权磁共振成像在描绘前列腺内恶性病变中的比较。
Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):438-45. doi: 10.1016/j.ijrobp.2015.02.004. Epub 2015 Apr 8.
5
Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.根治性前列腺切除术后复发性前列腺癌的检测:¹¹C-胆碱PET/CT与盆腔多参数磁共振成像联合直肠内线圈的比较
J Nucl Med. 2014 Feb;55(2):223-32. doi: 10.2967/jnumed.113.123018. Epub 2014 Jan 16.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.前列腺癌:采用磁共振成像、磁共振波谱及11C-胆碱PET/CT进行六分区定位
Radiology. 2007 Sep;244(3):797-806. doi: 10.1148/radiol.2443061063. Epub 2007 Jul 24.
8
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.对比增强磁共振成像与正电子发射断层扫描/计算机断层扫描联合评估卵巢肿块
Invest Radiol. 2014 Aug;49(8):524-31. doi: 10.1097/RLI.0000000000000050.
9
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.使用[11C]胆碱 PET-CT 作为一种非侵入性方法,用于检测前列腺癌的盆腔淋巴结状态及其与胆碱激酶表达的关系。
Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28.
10
Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.多参数 MRI 与全组织切片病理检查在前列腺癌定位中的相关性。
J Magn Reson Imaging. 2013 Jun;37(6):1392-401. doi: 10.1002/jmri.23938. Epub 2012 Nov 21.

引用本文的文献

1
Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer.雄激素剥夺治疗对前列腺癌局部放射治疗的表观扩散系数和 T2wMRI 直方图和纹理分析的影响。
Strahlenther Onkol. 2019 May;195(5):402-411. doi: 10.1007/s00066-018-1402-3. Epub 2018 Nov 26.
2
Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.动态对比增强磁共振成像在前列腺癌诊断中的准确性:系统评价与荟萃分析
Oncotarget. 2017 Aug 17;8(44):77975-77989. doi: 10.18632/oncotarget.20316. eCollection 2017 Sep 29.
3

本文引用的文献

1
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.[11C]胆碱 PET/CT 评估前列腺癌肿瘤体积:与手术标本的验证。
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):824-31. doi: 10.1007/s00259-013-2345-7. Epub 2013 Feb 7.
2
Functional MRI for radiotherapy dose painting.功能磁共振成像在放疗剂量描绘中的应用。
Magn Reson Imaging. 2012 Nov;30(9):1216-23. doi: 10.1016/j.mri.2012.04.010. Epub 2012 Jul 6.
3
Introducing parametric fusion PET/MRI of primary prostate cancer.介绍原发性前列腺癌的参数融合 PET/MRI。
(18)F-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer.
(18)放疗前 FDG PET 上的 FDG 摄取高的体积作为非小细胞肺癌的瘤床加量靶区勾画
Int J Clin Exp Med. 2015 May 15;8(5):7561-8. eCollection 2015.
4
Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.动态对比增强磁共振成像用于前列腺癌检测的荟萃分析。
AJR Am J Roentgenol. 2015 Apr;204(4):W439-48. doi: 10.2214/AJR.14.13373.
5
Clinical applications for diffusion magnetic resonance imaging in radiotherapy.扩散磁共振成像在放射治疗中的临床应用
Semin Radiat Oncol. 2014 Jul;24(3):218-26. doi: 10.1016/j.semradonc.2014.02.004.
J Nucl Med. 2012 Apr;53(4):546-51. doi: 10.2967/jnumed.111.091421. Epub 2012 Mar 14.
4
Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy.螺旋断层放疗对前列腺癌患者进行调强同步推量治疗。
Strahlenther Onkol. 2012 May;188(5):410-6. doi: 10.1007/s00066-012-0081-8. Epub 2012 Feb 26.
5
Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.基于扩散加权成像和动态对比增强磁共振成像的前列腺周围区肿瘤勾画模型的病理验证。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e537-44. doi: 10.1016/j.ijrobp.2011.07.021. Epub 2011 Dec 23.
6
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.(11)C-胆碱 PET 扫描在根治性前列腺放射治疗中靶区定义的组织病理学相关性。
Radiother Oncol. 2011 May;99(2):187-92. doi: 10.1016/j.radonc.2011.03.012. Epub 2011 May 18.
7
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU).评估前列腺癌(手术、放疗、冷冻治疗、HIFU)根治性治疗后局部复发的影像学和活检作用。
World J Urol. 2011 Oct;29(5):595-605. doi: 10.1007/s00345-011-0687-y. Epub 2011 May 8.
8
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.磁共振成像技术的进展:如何改变前列腺癌的治疗方式。
Eur Urol. 2011 Jun;59(6):962-77. doi: 10.1016/j.eururo.2011.02.034. Epub 2011 Feb 23.
9
Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer.在前列腺癌调强放疗计划中,通过 CT-MRI 图像融合定义 CTV 前列腺。
Strahlenther Onkol. 2011 Mar;187(3):183-90. doi: 10.1007/s00066-010-2179-1. Epub 2011 Feb 24.
10
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).前列腺癌:3T 下 1HMRS-DCEMR 与 [(18)F]胆碱 PET/CT 对根治性经耻骨后前列腺切除术(RRP)后生化复发的男性局部前列腺癌复发的检测比较。
Eur J Radiol. 2012 Apr;81(4):700-8. doi: 10.1016/j.ejrad.2011.01.095. Epub 2011 Feb 17.